mounjaro tirzepatide manufacturer company Practice Portal Eli Lilly's Mounjaro, Zepbound back

The increased use of GLP-1 medications presents an exciting opportunity to support Americans managing diabetes and weight loss, as well as those seeking to lead a healthier lifestyle, said Bob Nolan, vice president of demand science at Conagra Brands

In total, 5 studies included patients with T2DM (2427, 29) while another 6 studies evaluated patients with overweight or obesity without T2DM (10, 28, 30, 31, 33, 34)

Moving down just two levels on this scale is associated with a lower chance of long-term health problems

Acetylcholinesterase inhibition in patients with orthostatic intolerance

That is worth saying plainly, because the same review this page cites (Urbina 2026) found thiamine and cobalamin deficits increase over time on GLP-1 therapy, and that in patients with rapid weight loss, persistent vomiting, or very poor oral intake, suspected thiamine deficiency is a medical urgency